Daisy PETALs In Hand, Neurocrine Needs To Pick A Partner For Its Endometriosis Pain Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Daisy PETALs In Hand, Neurocrine Needs To Pick A Partner For Its Endometriosis Pain Drug
You may also be interested in...
Neurocrine Inks $575 Mil. Deal With Abbott To Develop and Sell Gynecologic, Elagolix
Elagolix could be the first oral drug approved for endometriosis that does not have severe side effects.
Neurocrine Inks $575 Mil. Deal With Abbott To Develop and Sell Gynecologic, Elagolix
Elagolix could be the first oral drug approved for endometriosis that does not have severe side effects.
Financings Of The Fortnight: Hybrigenics, Neurocrine, Xoma, Zogenix, Seaside
Creative, non-dilutive financings highlighted the fundraising activity over the past two weeks.